Attached files
| file | filename |
|---|---|
| EX-23.2 - EXHIBIT 23.2 - SUNOVION CNS DEVELOPMENT CANADA ULC | v433521_ex23-2.htm |
| EX-32.1 - EXHIBIT 32.1 - SUNOVION CNS DEVELOPMENT CANADA ULC | v433521_ex32-1.htm |
| EX-31.1 - EXHIBIT 31.1 - SUNOVION CNS DEVELOPMENT CANADA ULC | v433521_ex31-1.htm |
| EX-31.2 - EXHIBIT 31.2 - SUNOVION CNS DEVELOPMENT CANADA ULC | v433521_ex31-2.htm |
| EX-16.1 - EXHIBIT 16.1 - SUNOVION CNS DEVELOPMENT CANADA ULC | v433521_ex16-1.htm |
| EX-23.1 - EXHIBIT 23.1 - SUNOVION CNS DEVELOPMENT CANADA ULC | v433521_ex23-1.htm |
| 10-K - FORM 10-K - SUNOVION CNS DEVELOPMENT CANADA ULC | v433521_10k.htm |
Exhibit 21.1
Subsidiary of Cynapsus Therapeutics Inc.
Cynapsus Therapeutics (USA) Inc., a Delaware corporation